Literature DB >> 7541668

Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation.

K Muta1, S B Krantz, M C Bondurant, C H Dai.   

Abstract

Stem cell factor (SCF), the ligand for the c-kit tyrosine kinase receptor, markedly stimulates the accumulation of erythroid progenitor cells in vitro. We now report that SCF delays erythroid differentiation among the progeny of individual erythroid progenitors while greatly increasing the proliferation of these progeny. These effects appear to be independent of an effect on maintenance of cell viability. Highly purified day-6 erythroid colony-forming cells (ECFC), consisting mainly of colony-forming units-erythroid (CFU-E), were generated from human peripheral blood burst-forming units-erythroid (BFU-E). Addition of SCF to the ECFC in serum-free liquid culture, together with erythropoietin (EP) and insulin-like growth factor 1 (IGF-1), resulted in a marked increase in DNA synthesis, associated with a delayed peak in cellular benzidine positivity and a delayed incorporation of 59Fe into hemoglobin compared with cultures without SCF. In the presence of SCF, the number of ECFC was greatly expanded during this culture period, and total production of benzidine-positive cells plus hemoglobin synthesis were ultimately increased. To determine the effect of SCF on individual ECFC, single-cell cultures were performed in both semisolid and liquid media. These cultures demonstrated that SCF, in the presence of EP and IGF-1, acted on single cells and their descendants to delay erythroid differentiation while substantially stimulating cellular proliferation, without an enhancement of viability of the initial cells. This was also evident when the effect of SCF was determined using clones of ECFC derived from single BFU-E. Our experiments demonstrate that SCF acts on individual day-6 ECFC to retard erythroid differentiation while simultaneously providing enhanced proliferation by a process apparently independent of an effect on cell viability or programmed cell death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541668

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Signaling and cytoskeletal requirements in erythroblast enucleation.

Authors:  Diamantis G Konstantinidis; Suvarnamala Pushkaran; James F Johnson; Jose A Cancelas; Stefanos Manganaris; Chad E Harris; David A Williams; Yi Zheng; Theodosia A Kalfa
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

2.  Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling.

Authors:  A-S Gabet; S Coulon; A Fricot; J Vandekerckhove; Y Chang; J-A Ribeil; L Lordier; Y Zermati; V Asnafi; Z Belaid; N Debili; W Vainchenker; B Varet; O Hermine; G Courtois
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

3.  Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin.

Authors:  Melissa M Rhodes; Prapaporn Kopsombut; Maurice C Bondurant; James O Price; Mark J Koury
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

4.  BMP4, SCF, and hypoxia cooperatively regulate the expansion of murine stress erythroid progenitors.

Authors:  John M Perry; Omid F Harandi; Robert F Paulson
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

Review 5.  Erythroblastic islands: niches for erythropoiesis.

Authors:  Joel Anne Chasis; Narla Mohandas
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

6.  Kit transduced signals counteract erythroid maturation by MAPK-dependent modulation of erythropoietin signaling and apoptosis induction in mouse fetal liver.

Authors:  N Haas; T Riedt; Z Labbaf; K Baßler; D Gergis; H Fröhlich; I Gütgemann; V Janzen; H Schorle
Journal:  Cell Death Differ       Date:  2014-10-17       Impact factor: 15.828

7.  The p53 tumour suppressor inhibits glucocorticoid-induced proliferation of erythroid progenitors.

Authors:  Gitali Ganguli; Jonathan Back; Sagar Sengupta; Bohdan Wasylyk
Journal:  EMBO Rep       Date:  2002-05-24       Impact factor: 8.807

Review 8.  Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis.

Authors:  F Morceau; M Dicato; M Diederich
Journal:  Mediators Inflamm       Date:  2010-03-01       Impact factor: 4.711

9.  Dynamics of human erythroblast enucleation.

Authors:  Miwa Hebiguchi; Makoto Hirokawa; Yong-Mei Guo; Kunie Saito; Hideki Wakui; Atsushi Komatsuda; Naohito Fujishima; Naoto Takahashi; Tsutomu Takahashi; Takehiko Sasaki; Wataru Nunomura; Yuichi Takakuwa; Kenichi Sawada
Journal:  Int J Hematol       Date:  2008-12-02       Impact factor: 2.490

10.  Erythropoietin down-regulates stem cell factor receptor (Kit) expression in the leukemic proerythroblast: role of Lyn kinase.

Authors:  Olivier Kosmider; Dorothée Buet; Isabelle Gallais; Nicole Denis; Françoise Moreau-Gachelin
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.